drug protocol number

CNTO1959CRD3005

drug sponsor

Janssen Research & Development LLC

drug study

Guselkumab

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Saud Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)

drug status

Ongoing

drug phase